DNAAF1 Gene Primary Ciliary Dyskinesia Type 13 NGS Genetic DNA Test
Comprehensive Genetic Testing for Respiratory Health
The DNAAF1 Gene Primary Ciliary Dyskinesia Type 13 NGS Genetic DNA Test represents a cutting-edge diagnostic approach for identifying genetic mutations associated with Primary Ciliary Dyskinesia (PCD), a rare inherited disorder affecting the structure and function of cilia throughout the body. This sophisticated genetic analysis provides crucial insights for patients experiencing chronic respiratory symptoms and helps establish definitive diagnoses that guide appropriate medical management.
What Does This Test Measure?
This advanced genetic test specifically targets the DNAAF1 gene, which plays a critical role in the proper assembly and function of motile cilia. Using next-generation sequencing (NGS) technology, the test comprehensively analyzes the entire DNAAF1 gene sequence to identify:
- Pathogenic mutations causing Primary Ciliary Dyskinesia Type 13
- Single nucleotide variants (SNVs) affecting ciliary protein function
- Insertions and deletions that disrupt normal gene expression
- Copy number variations impacting gene dosage
- Splice site mutations altering protein production
Who Should Consider This Genetic Test?
This DNAAF1 gene test is particularly recommended for individuals presenting with the following symptoms or clinical scenarios:
- Chronic respiratory distress beginning in infancy or early childhood
- Recurrent sinus infections and persistent nasal congestion
- Frequent middle ear infections requiring multiple treatments
- Chronic wet cough that persists despite standard therapies
- Bronchiectasis or chronic lung damage visible on imaging
- Neonatal respiratory distress requiring extended oxygen support
- Laterality defects such as situs inversus or heterotaxy
- Male infertility due to impaired sperm motility
- Family history of Primary Ciliary Dyskinesia or related conditions
Significant Benefits of DNAAF1 Genetic Testing
Undergoing DNAAF1 gene analysis provides numerous advantages for patients and healthcare providers:
- Accurate Diagnosis: Confirms or rules out Primary Ciliary Dyskinesia Type 13 with high precision
- Personalized Treatment: Enables targeted management strategies for respiratory symptoms
- Family Planning: Provides crucial information for genetic counseling and reproductive decisions
- Early Intervention: Facilitates proactive management to prevent long-term complications
- Differential Diagnosis: Helps distinguish PCD from other chronic respiratory conditions
- Research Contribution: Advances understanding of ciliary disorders and treatment options
Understanding Your Test Results
After completing the DNAAF1 gene analysis, you will receive a comprehensive report detailing the genetic findings:
- Positive Result: Indicates the presence of pathogenic mutations in the DNAAF1 gene, confirming Primary Ciliary Dyskinesia Type 13 diagnosis
- Negative Result: Suggests no disease-causing variants were detected in the DNAAF1 gene
- Variant of Uncertain Significance (VUS): Identifies genetic changes with unclear clinical implications requiring further evaluation
- Carrier Status: Determines if an individual carries one copy of a mutated gene without showing symptoms
All results are accompanied by detailed interpretation and recommendations for next steps, including consultation with genetic specialists and ENT doctors for comprehensive care planning.
Test Pricing and Availability
| Test Component | Price (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type | Blood, Extracted DNA, or One Drop Blood on FTA Card |
Nationwide Testing Accessibility
We proudly offer comprehensive genetic testing services across the United States, with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many other cities. Our network of certified genetic counselors and specialized ENT doctors ensures you receive expert care regardless of your location.
Take Control of Your Respiratory Health Today
Don’t let unexplained respiratory symptoms compromise your quality of life. The DNAAF1 Gene Primary Ciliary Dyskinesia Type 13 NGS Genetic DNA Test provides the definitive answers you need for proper diagnosis and effective treatment. Our advanced NGS technology, combined with expert genetic analysis, delivers reliable results you can trust.
Ready to schedule your genetic test? Contact our dedicated team today at +1(267) 388-9828 or book your appointment online. Take the first step toward understanding your genetic health and achieving better respiratory outcomes.
